The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Path: Diffuse alveolar damage (DAD-pattern) (see also IL)
Publications
Fatal diffuse alveolar damage associated with oxaliplatin administration.
Clinical colorectal cancer. 2011;10(3):198-202
Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma.
Cancer chemotherapy and pharmacology. 2010;65(3):607-10
Structural lung damage after chemotherapy fact or fiction?
Lung cancer (Amsterdam, Netherlands). 2010;67(3):306-10
Maniwa K, Tanaka E, Inoue T, Kato T, Sakuramoto M, Minakuchi M, Maeda Y, Noma S, Kobashi Y, Taguchi Y
An autopsy case of acute pulmonary toxicity associated with gemcitabine.
Internal medicine (Tokyo, Japan). 2003;42(10):1022-5
Acute respiratory distress syndrome following intrathecal methotrexate administration: a case report and review of literature.
Annals of hematology. 2000;79(12):696-9
Pulmonary drug toxicity: radiologic and pathologic manifestations.
Radiographics : a review publication of the Radiological Society of North America, Inc. 2000;20(5):1245-59
[Cytostatic pneumopathy following chemotherapy for metastasizing breast neoplasm].
Schweizerische medizinische Wochenschrift. 1977;107(40):1412-7